头孢他啶-阿维巴坦：用于治疗复杂性尿路感染的新型抗菌组合。
Ceftazidime-avibactam: novel antimicrobial combination for the treatment of complicated urinary tract infections.
作者信息
Alidjanov Jakhongir F, Fritzenwanker Moritz, Hoffman Ivan, Wagenlehner Florian M
机构信息
Clinic & Policlinic for Urology, Pediatric Urology & Andrology, Justus-Liebig University, Giessen, Germany.
Outpatient Department, JSC "Republican Specialized Center of Urology", Tashkent, Uzbekistan.
出版信息
Future Microbiol. 2017 Jun;12:655-670. doi: 10.2217/fmb-2016-0213. Epub 2017 Mar 24.
Ceftazidime-avibactam is a combination of a third-generation cephalosporin and a novel non-beta-lactam beta-lactamase inhibitor. This combination was recently recommended for the treatment of complicated urinary tract infections, including acute pyelonephritis, in adults with limited or no alternative treatment options. The current review is aimed to determine activity, efficacy and safety of ceftazidime-avibactam in the treatment of patients with complicated urinary tract infections.
头孢他啶-阿维巴坦是第三代头孢菌素与新型非β-内酰胺类β-内酰胺酶抑制剂的组合。最近，对于治疗选择有限或没有其他选择的成人复杂性尿路感染，包括急性肾盂肾炎，推荐使用这种组合。本综述旨在确定头孢他啶-阿维巴坦治疗复杂性尿路感染患者的活性、疗效和安全性。
Zotero 插件